Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy
Conditions: Non-seminomatous Germ Cell Tumors; MetastasisInterventions: Other: K5-RGD PET; Other: FDGSponsor: Centre Francois BaclesseRecruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials